Vitrolife AB (VITRs)

BATS Europe


Symbol		Exchange		Currency
VITR	·	Stockholm	·	SEK	Real-time
VITRs	·	BATS Europe	·	SEK	Delayed
0YAY	·	London	·	SEK	Real-time

Currency in SEK

145.35

+4.20(+2.98%)

Delayed Data·11:00:59

Fair Value

Unlock Value

Day's Range

145.35

52 wk Range

135.20

263.50

VITRs Income Statement

Featured here, the Income Statement (earnings report) for Vitrolife AB, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

1,245.57

1,681

3,234

3,512

3,609

Total Revenues Growth

aa.aa

-15.85%

+34.96%

+92.39%

+8.6%

+2.76%

Cost Of Revenues

aa.aa

477.91

635

1,454

1,534

1,470

Gross Profit

aa.aa

767.67

1,046

1,780

1,978

2,139

Gross Profit Growth

aa.aa

-18.22%

+36.26%

+70.17%

+11.12%

+8.14%

Gross Profit Margin %

aa.aa

61.63%

62.22%

55.04%

56.32%

59.27%

Other Operating Expenses, Total

aa.aa

400.56

617

1,133

1,240

1,348

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-11.08%	+54.04%	+83.63%	+9.44%	+8.71%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	91.76	114	143	127	117
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	311.35	503	1,002	1,117	1,232
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.55	0	-12	-4	-1

Operating Income

aa.aa

367.11

429

647

738

791

Operating Income Growth

aa.aa

-24.8%

+16.86%

+50.82%

+14.06%

+7.18%

EBIT Margin %

aa.aa

29.47%

25.52%

20.01%

21.01%

21.92%

Net Interest Expenses

aa.aa

-1.33

-9

-42

-78

-74

Net Interest Expenses Growth

aa.aa

-67.42%

-578.73%

-366.67%

-85.71%

+5.13%

Interest Expense, Total

aa.aa

-2.09

-10

-44

-94

-98

Interest And Investment Income

aa.aa

0.76

Other Non Operating Expenses, Total

aa.aa

-17.16

-50

-69

-40

EBT, Excl. Unusual Items

aa.aa

348.62

460

555

591

677

Gain (Loss) On Sale Of Assets

aa.aa

-0.05

-23

-3

-4

Other Unusual Items, Total

aa.aa

8.7

-50

EBT, Incl. Unusual Items

aa.aa

366.19

460

537

-3,712

674

EBT, Incl. Unusual Items Growth

aa.aa

-25.68%

+25.62%

+16.74%

-791.25%

+118.16%

EBT, Incl. Unusual Items Margin

aa.aa

29.4%

27.36%

16.6%

-105.69%

18.68%

Income Tax Expense

aa.aa

78.33

116

143

139

160

Net Income to Company

aa.aa

287.87

344

394

-3,851

514

Minority Interest

aa.aa

-1.02

-3

-1

Net Income

aa.aa

286.85

341

394

-3,851

513

Net Income Growth

aa.aa

-25.06%

+18.88%

+15.54%

-1,077.41%

+113.32%

Net Income Margin %

aa.aa

23.03%

20.29%

12.18%

-109.65%

14.21%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

286.85

341

394

-3,851

513

Basic EPS - Continuing Operations

aa.aa

2.64

2.97

2.91

-28.44

3.79

Basic EPS - Continuing Operations Growth

aa.aa

-25.06%

+12.58%

-2.18%

-1,077.41%

+113.32%

Diluted EPS - Continuing Operations

aa.aa

2.64

2.97

2.91

-28.44

3.78

Diluted EPS - Continuing Operations Growth

aa.aa

-25.06%

+12.58%

-2.18%

-1,077.41%

+113.29%

Basic Weighted Average Shares Outstanding

aa.aa

108.55

114.63

135.39

135.41

Diluted Weighted Average Shares Outstanding

aa.aa

108.55

114.63

135.39

135.52

Dividend Per Share

aa.aa

0.8

0.85

1.1

Dividend Per Share Growth

aa.aa

+6.25%

+17.65%

+10%

EBITDA

aa.aa

420.88

506

991

1,107

1,167

EBITDA Growth

aa.aa

-24.79%

+20.22%

+95.85%

+11.71%

+5.42%

EBITDA Margin %

aa.aa

33.79%

30.1%

30.64%

31.52%

32.34%

EBIT

aa.aa

367.11

429

647

738

791

* In Millions of SEK (except for per share items)

NSE 30

5,058.48

+104.41

+2.11%

NSE All Share

137,953.92

+2,787.41

+2.06%

US 30

44,850.50

+12.9

+0.03%

US 500

6,403.50

+13.7

+0.21%

FTSE 100

9,146.85

+65.41

+0.72%

DAX

24,276.03

+331.52

+1.38%

South Africa Top 40

91,538.61

+441.15

+0.48%

Market Movers

Name	Last	Chg. %	Vol.
Fidelitybk	20.900	-0.48%	108.30M
Guaranty Trust Holding	98.35	+4.52%	24.83M
UBA	48.00	+2.89%	21.91M
Zenith Bank	73.00	+0.41%	14.48M
STANBIC IBTC Bank	102.00	+2.26%	13.57M
MTN Nigeria	451.60	+9.99%	8.01M
Okomu Oil Palm	1,086.10	+8.61%	2.87M

Name	Last	Chg. %	Vol.
SCOA Nigeria	5.500	+10.00%	43.00K
Airtel Africa	2,541.50	+10.00%	95.00
Union Dicon Salt	9.90	+10.00%	25.77K
Thomaswy	3.19	+10.00%	2.11M
Berger Paints	34.10	+10.00%	1.29M
Custodian Allied	33.55	+10.00%	786.02K
Skye Shelter Fund	274.15	+9.99%	36.47K

Name	Last	Chg. %	Vol.
Transcorp Power	288.00	-10.00%	84.27K
Geregu Power	1,027.40	-10.00%	7.06K
Abbey Mortgage Bank	7.20	-10.00%	200.17K
Northern Nigeria Flour Mills	93.15	-10.00%	1.72M
Conoil	211.10	-9.98%	102.99K
Livingtrust Mortgage Bank	6.59	-9.97%	6.64K
Vitafoam Nig	79.10	-9.96%	741.91K

Trending Stocks

Name	Last	Chg. %	Vol.
Initiates	15.35	+5.72%	6.74M
Aradel Holdings	512.70	+1.12%	900.05K
Okomu Oil Palm	1,086.10	+8.61%	2.87M
VFD PLC	13.50	+3.85%	14.07M
Access Holdings	27.20	-0.37%	30.57M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaa	5,379.90	+34.49%	7,235.43
Aaaaaaaaaa Aa	68.90	+28.35%	88.43
Aaaaaaaaaa Aaaaaaaaa	514.90	+27.29%	655.42
Aaaaaaaaa	127.00	+22.72%	155.85

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Vitrolife AB (VITRs)

VITRs Income Statement

Trending Stocks